DANIEL SOLAND

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ACADIA PHARMACEUTICALS INC

Filing Date Source Excerpt
2016-04-29 Daniel Soland 48,750 724,465 Fees Earned or Paid in Cash includes a pro-rated Annual Retainer of $8,750 for services performed through May 2015, the Annual Retainer of $35,000, and Additional Retainer for Nominating and Corporate Governance Member (non-Chair) of $5,000.
2017-04-27 Daniel Soland 59 Director
2018-04-30 Daniel Soland(8) Fees Earned or Paid in Cash includes Annual Retainer of $50,000, Additional Retainer for Audit Member (non-Chair) of $10,000, Additional Retainer for Nominating and Corporate Governance Chair of $10,000. Option Awards includes the fair value of 15,000 stock options granted June 13, 2017 with an exercise price of $27.25 and the fair value of 15,000 stock options granted July 17, 2017 with an exercise price of $28.85 for being a member of the Commercial Committee. As of December 31, 2017, an aggregate of 70,000 stock options that had been granted to Mr. Soland were outstanding.
2019-04-30 Daniel Soland - Director, age 61. He serves on the Audit Committee and is Chair of the Nominating and Corporate Governance Committee. 2018 compensation: $412,567.

Data sourced from SEC filings. Last updated: 2026-03-14